These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17390479)

  • 1. Anti-HIV agents. Non-nukes and the brain.
    TreatmentUpdate; 2007 Jan; 19(1):6. PubMed ID: 17390479
    [No Abstract]   [Full Text] [Related]  

  • 2. The nukes. Each one works a little differently.
    Clay PG
    Posit Aware; 2005; Spec No():8-11. PubMed ID: 15828102
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications & side effects. Nukes and fat wasting.
    TreatmentUpdate; 2004; 16(7):3-4. PubMed ID: 17225282
    [No Abstract]   [Full Text] [Related]  

  • 4. Autralian study links nukes, lactic acid to bone loss.
    TreatmentUpdate; 2001 May; 13(1):5-6. PubMed ID: 11570258
    [No Abstract]   [Full Text] [Related]  

  • 5. Delavirdine (Rescriptor).
    Res Initiat Treat Action; 2000 Mar; 6(1):20-1. PubMed ID: 11708180
    [No Abstract]   [Full Text] [Related]  

  • 6. Zalcitabine (Hivid).
    Res Initiat Treat Action; 2000 Mar; 6(1):10-1. PubMed ID: 11708175
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone damage--more than just nukes involved.
    TreatmentUpdate; 2001 May; 13(1):6-8. PubMed ID: 11570259
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effects. Nukes and fat cell damage.
    TreatmentUpdate; 2000 Aug; 12(5):2-3. PubMed ID: 12125606
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel treatment options for pediatric HIV infection.
    Day E; Buckberry K; Sharland MR; Chakraborty R
    Curr Opin Investig Drugs; 2008 Feb; 9(2):170-5. PubMed ID: 18246519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of HIV-1 reverse transcriptase.
    Ilina T; Parniak MA
    Adv Pharmacol; 2008; 56():121-67. PubMed ID: 18086411
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness and durability of non-nucleoside reverse transcriptase inhibitor-based therapy in HIV clinical practice.
    Kan VL
    AIDS; 2007 Apr; 21(7):880-2. PubMed ID: 17415048
    [No Abstract]   [Full Text] [Related]  

  • 12. Check-ups for the power plant?
    TreatmentUpdate; 2002 Mar; 14(3):2. PubMed ID: 12033186
    [No Abstract]   [Full Text] [Related]  

  • 13. Revisiting the concept of a genetic barrier to resistance.
    Rusconi S
    J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
    [No Abstract]   [Full Text] [Related]  

  • 14. Nucleoside analogues in 2008.
    Warwick Z; Churchill D
    J HIV Ther; 2008 Mar; 13(1):3-8. PubMed ID: 18953267
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent highlights in clinical AIDS research.
    Laurence J
    AIDS Read; 2008 Feb; 18(2):64-6. PubMed ID: 18330032
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 18. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
    Williams I
    J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

  • 20. To nuke, or not to nuke?
    Proj Inf Perspect; 2007 Apr; (43):1-3. PubMed ID: 17684823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.